Peter Wang leads the Firm's China antitrust and litigation practices. He has handled major U.S. and Chinese government antitrust investigations of proposed mergers and acquisitions, as well as nonmerger investigations and antitrust litigation. Peter represents clients inside and outside of China in complex commercial disputes and patent and other technology and intellectual property litigation. He also regularly handles Foreign Corrupt Practices Act (FCPA) investigations and advises clients on related compliance and due diligence issues.
Among the China and U.S. antitrust matters Peter has handled include Bombardier Transportation's acquisition by Alstom, NVIDIA's acquisition of Mellanox, Baxter's acquisition of Gambro, Gavilon's acquisition by Marubeni, TI's acquisition of National Semiconductor, Alcatel's merger with Lucent, America Online's merger with Time Warner, and Procter & Gamble's acquisition of Clairol. He also has represented Chinese, U.S., and other clients in litigation including First American v. Zayed (RICO and related criminal, civil, and regulatory investigations and litigation), Hong Yi Construction v. Thomson Consumer Electronics (contract and RICO action), Sinochem International v. MISC (U.S. Supreme Court litigation re forum non conveniens), and AlliedSignal v. BFGoodrich (antitrust challenge to proposed acquisition).
Throughout his career, Peter has been active in the Firm's extensive pro bono practice, including substantial work for the Whitman-Walker Clinic, Appleseed, the DC Bar Free Legal Advice & Referral Clinic (for which the Firm received a DC Bar pro bono award), and litigation matters such as Native Village of Curyung v. State of Alaska (for which the Firm received a certificate of merit from Alaska Legal Services).
Additional Publications
- January 2014
Competition Law in China: Laws, Regulations, and Cases, Oxford University Press - March 2012
Chapter on China, Antitrust Issues in International Intellectual Property Licensing Transactions, American Bar Association - December 2011
Avoiding delays from Chinese merger review, The Deal Pipeline - September 2011
China Merger Review: A New Gauntlet for Global M&A, The M&A Lawyer - 2011
Anti-Monopoly Law and Practice in China, Oxford University Press - April 2011
China: next stop in the race for leniency?, Global Competition Review - October 12, 2010
Life After China's Anti-Monopoly Law; Foreign Companies are Discovering they Might Not be the Law's Prime Targets After All, The Wall Street Journal - October 7, 2010
New Whistleblower Incentives Stress FCPA Compliance, Insight, Legal Update - September 2009
Proposed new rules promote anti-monopoly enforcement, China Daily - Winter 2006
Patent Litigation in Chinese Courts
Speaking Engagements
- June 15-16, 2017
8th Annual Chicago Forum on International Antitrust Issues - January 26, 2016
CLE Academy Shanghai 2016 - Decenber 3, 2015
Presentation on U.S. & China Antitrust Developments - October 7, 2015
International Antitrust Conference: Antitrust Worldwide for Companies in Texas - September 26, 2015
PwC China’s Forensics Roundtable: Compliance Management - Is a Program Enough? - May 7, 2015
China Antitrust Enforcement: Handling Uncertainty, Intellectual Property Owners Association (IPO) - April 2, 2015
Handling Overseas and China Antimonopoly Investigations, 4th Advanced Seminar on China Antitrust, American Conference Institute - October 23, 2014
Handling Antimonopoly Problems in China - September 18, 2014
Handling Antimonopoly Problems in China - December 3, 2013
International Investigations in the Age of the Whistleblower: Views from Around the World, Jones Day CLE Academy 2013 - October 24, 2013
Managing Antitrust Risk, CLE program hosted by the Legal Committee of the American Chamber of Commerce (AmCham) - October 8, 2013
Current Issues in FCPA Compliance – Meet Our Professionals From Around the World - August 28, 2013
FCPA Roundtable - 28. Mai 2013
Grenzüberschreitende Kartellrechtsdurchsetzung und –verteidigung - October 25, 2012
China Inbound Seminar: New Challenges and Opportunities for Foreign Investments in China - 2012年10月25日
在华投资研讨会：外商对华投资新的挑战和机遇 - October 24, 2012
Outbound Seminar "Managing Legal Risks in Global Expansion of Chinese Companies" - 2012年10月24日
对外投资研讨会：中国公司全球扩展中的法律风险管理 - July 25, 2012
Jones Day: Global Viewpoints - April 7, 2011
JDialog: Investments in China - Current Developments and Challenges - April 5, 2011
JDialog: Investments in China - Chances & Challenges - November 18, 2010
Insights into China's Anti-Monopoly Law - November 2010
中国法セミナー分科会 - November 2010
中国法セミナー: 変化を続ける企業法制－日本企業にとってのリスクとは－ - 2005年11月29日
第一届“中国因素”执行小组、中国服务组和亚洲业务资源组 - November 29, 2005
1st Annual "The China Factor" Executive Panel, the Chinese Services Group and the Asian Business Resource Group - December 12, 2003
Managing Business Risk in Greater China: Fraud & Corruption - 2003年12月12日
大中华区的管理业务风险：欺诈和腐败
- University of California, Berkeley (J.D. 1992); Princeton University (A.B. in Molecular Biology 1989)
- California (USA), District of Columbia (USA), and Hong Kong
Recognized by Chambers Asia for competition/antitrust (Band 1) as a leading individual: "brings years of experience of handling both Chinese and US competition litigation" and "sources respect him for his knowledge base and impressive technical skills"
Recommended by PLC Which lawyer? for competition/antitrust: cross-border advice (China)